FUNCTIONS OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
FUNCTIONS OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
批准号:
6472778
负责人:
TOWIA A. LIBERMANN
金额:
$27.95万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-06 至 2003-06-30
关键词:
B lymphocyte antisense nucleic acid developmental genetics gene induction /repression genetic promoter element genetically modified animals immunogenetics laboratory mouse leukemia leukopoiesis lymphoma neoplasm /cancer genetics oligonucleotides pluripotent stem cells protein protein interaction site directed mutagenesis transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our goal is to understand how embryonic pluripotent cells differentiate
into specific cell types of the immune system and to identify
developmental defects leading to leukemia and lymphoma formation.
Our approach is to analyze transcriptional control mechanisms for
developmentally regulated beta cell-specific gene and isolated a novel Ets
factor, NERF, with three alternative splice forms form human spleen and
fetal liver. NERF is closely related to ELF-1, and Ets factor linked to
T cell-specific gene expression; however, our preliminary results indicate
that ELF-1 is a major Beta cell nuclear factor which interacts with the
activates regulatory elements in Beta cell-specific genes. NERF and
ELF-1 are highly expressed in early stages of Beta cell development and
bind with similar affinity to Ets sites in several Beta cell-specific genes
the highest affinity is for the Beta cell tyrosine kinase genes, lyn & blk.
We propose to investigate the role and mechanism of action of NERF
and ELF-1 in regulating Beta cell-specific genes using the blk gene as
one apparent target gene. Our aim is to evaluate the role of NERF in
Beta cell development and analyze structure/function relationships of
NERF and ELF-1 to understand mechanisms responsible for functional
differences between these two factors. Thus, the specific aims are to:
Specific AIM number 1. Determine the role of NERF and ELF-1 in the
regulation of Beta cell specific blk gene expression.
Specific Aim number 2. Determine the role of protein-protein
interactions and phosphorylation in the function of ELF-1 or NERF.
Specific Aim number 3. Determine the effect of targeted disruption of
the NERF gene on Beta cell development and blk gene expression.
Due to the importance of the Ets family in regulation of various tissue-
and differentiation-specific genes, in general, and hematopoiesis, in
particular, NERF and ELF-1 are expected to play a central role in Beta
cell development. Elucidation of the function NERF and ELF-1 in
regulating Beta cell development will provide exciting opportunities to
test the hypothesis that altered functions of these Ets factor result in
leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
-
批准号:9204773
-
项目类别:
-
资助金额:$60.25万
-
财政年份:2016
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
-
批准号:9402039
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2016
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Role of Axl in docetaxel resistance in prostate cancer
-
批准号:8880713
-
项目类别:
-
资助金额:$21.11万
-
财政年份:2015
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline
-
批准号:10585942
-
项目类别:
-
资助金额:$87.41万
-
财政年份:2015
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Novel treatment strategies for enhancing sunitinib response in renal cell cancer
-
批准号:8524387
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2013
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Novel treatment strategies for enhancing sunitinib response in renal cell cancer
-
批准号:8651433
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2013
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER
-
批准号:6870870
-
项目类别:
-
资助金额:$14.62万
-
财政年份:2005
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER
-
批准号:7060081
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2005
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
CORE-- GENOMIC AND BIONFORMATICS SUPPORT
-
批准号:6946588
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2004
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6886322
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6266267
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6511364
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6633648
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6873688
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6709419
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6632335
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
Ese-1, a New Transcriptional Mediator of Inflammation
-
批准号:6321886
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6514408
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
-
批准号:6724785
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2001
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
NIDDK BIOTECHNOLOGY CENTER
-
批准号:6230920
-
项目类别:
-
资助金额:$43.48万
-
财政年份:2000
-
负责人:TOWIA A. LIBERMANN
-
依托单位:
海外基金